SCHEMBL26280704

SCHEMBL26280704

CCn1c(=O)n(C)c2cc(NN=C(C)C)cnc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.38
▸ HSD17B10 Q99714 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ HTT P42858 2/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ TDP1 Q9NUW8 2/20 0.37
▸ PKM P14618 1/20 0.37
▸ PDE4A P27815 2/20 0.36
▸ ADORA2A P29274 2/20 0.36
▸ PDE4B Q07343 2/20 0.36
▸ PDE4C Q08493 2/20 0.36
▸ PDE4D Q08499 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ ADORA2B P29275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26280613 0.91 MAPT (0.39) MAPTHSD17B10HPGDHTTALDH1A1
SCHEMBL26279899 0.87 HSD17B10 (0.50) MAPTHSD17B10HPGDHTTALDH1A1
SCHEMBL24130682 0.86 MAPT (0.37) MAPTHSD17B10HPGDHTTALDH1A1
SCHEMBL26280755 0.86 MEN1 (0.32) MAPTHPGDMEN1BLMPMP22
SCHEMBL26280725 0.84 TNF (0.35) MAPTHPGDALDH1A1KDM4ETDP1
SCHEMBL26280884 0.82 TNF (0.35) MAPTHPGDALDH1A1KDM4ETDP1
SCHEMBL26280805 0.80 EEF2K (0.40) PDE4BPDE4DGRIN1GRIN2B
SCHEMBL26280865 0.80 MAPT (0.40) MAPTHSD17B10HPGDHTTALDH1A1
SCHEMBL26280780 0.78 PRKDC (0.43) —
SCHEMBL26280462 0.78 SMN1; SMN2 (0.47) MAPTHSD17B10HTTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2023-09-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295095-A1 NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF CBR3, DBF4, DDT MAPT 3518/4885HSD17B10 626/4885HPGD 938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback